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Microarray analysis of retinal gene expression in chicks during
imposed myopic defocus
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Purpose: The retina plays an important regulatory role in ocular growth. To screen for new retinal candidate genes that
could be involved in the inhibition of ocular growth, we used chick microarrays to analyze the changes in retinal mRNA
expression after myopic defocus was imposed by positive lens wear.
Methods: Four male white leghorn chicks, aged nine days, wore +6.9D spectacle lenses over both eyes for 24 h. Four
untreated age-matched male chicks from the same batch served as controls. The chicks were euthanized, and retinas from
both eyes of each chick were pooled. RNA was isolated and labeled cRNA was prepared. These samples were hybridized
to Affymetrix GeneChip Chicken Genome arrays with more than 28,000 characterized genes. After comparison of multiple
normalization methods, GC-RMA and a false-discovery rate of 6% was chosen for normalization of the data. The
expression  of  16  candidate  genes  was  further  studied,  using  semiquantitative  real-time  RT–PCR.  In  addition,  the
expression of the mRNA of some of these candidate genes was assessed in chicks that wore either +6.9D lenses for 4 h
or −7D lenses for 24 h.
Results: 123 transcripts were found to be differentially expressed (p<0.05; at least 1.5-fold change in expression level),
with an absolute mean fold-change of 1.97±1.16 (mean±standard deviation). Nine of the sixteen genes that were examined
by real-time RT–PCR were validated. Regardless of whether positive or negative lenses were worn, six of these nine genes
were regulated in the same direction after 24 h: arginyltransferase 1 (ATE1), E74-like factor 1 (ELF1), growth factor
receptor-bound protein 2 (GRB2), SHQ1 homolog (S. cerevisiae) (SHQ1), spectrin, beta, non-erythrocytic 1 (SPTBN1),
prepro-urotensin II-related peptide (pp-URP). Three genes responded differently to positive and negative lens treatment
after 24 h: ATP-binding cassette, sub-family C, member 10 (ABCC10), CD226 molecule (CD226) and oxysterol binding
protein 2 (OSBP2).
Conclusions: The validated genes that were regulated only by myopic defocus may represent elements in a pathway
generating a “stop-signal” for eye growth. Some of the genes identified in this study have so far not been described in the
retina. Further investigation of their function may improve the understanding of the signaling cascades in emmetropization.
More general, published microarray data are variable among different animal models (mouse, chick, monkeys), tissues
(retina, retina/retinal pigment epithelium), treatments (diffusers, lenses, lid-suture), as well as different treatment durations
(hours, days), and comparisons remain difficult. That only a small number of common genes were found emphasizes the
need for careful normalization of the experimental parameters.
The high incidence of myopia is a problem throughout
the industrialized world, especially in Southeast Asia [1-3].
Although it is generally accepted that there is a major genetic
influence, it has become clear that the visual experience is
important as well [4,5]. Studies in several animal models (e.g.,
tree shrew, chick, monkey, guinea pig, mouse) have shown
that  manipulating  the  retinal  image  features  can  induce
alterations in the rate of ocular growth [6-10]. Treatment with
negative  lenses  (hyperopic  defocus)  or  diffusers  leads  to
myopia,  while  treatment  with  positive  lenses  (myopic
defocus) induces the development of hyperopia. Experiments
in which the optic nerve of deprived and lens-treated animals
was sectioned revealed that an intact link between the retina
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and  the  brain  is  not  necessary  for  the  development  of
experimental  myopia  or  hyperopia  [11-13].  These
experiments  show  that  the  retina  controls  refractive
development by processing visual signals largely without the
involvement of the brain. However, the biochemical pathways
underlying these processes require further characterization.
Changes in retinal concentrations of several substances
have been demonstrated to be associated with altered eye
growth, including dopamine [14], glucagon [15-17], early
growth response factor-1 (EGR1 or ZENK) [18-21], retinoic
acid [22-24], vasoactive intestinal polypeptide [13,25], and
others [26]. Recently, microarray studies provided further
candidates in chicks, monkeys and mice [27-29]. A study
performed by McGlinn et al. [27] on retina, retina/retinal
pigment  epithelium  (RPE)  tissue  of  form-deprived  chicks
revealed new genes such as bone morphogenetic protein 2,
prepro-urotensin II-related peptide (pp-URP) and mitogen-
activated protein kinase phosphatase 2. The authors found that
the  changes  in  mRNA  expression  induced  by  form-
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1589deprivation were small, and that only a small number of genes
showed any responses. Brand et al. [28] found significant
changes in the mRNA concentration of Egr1, the Finkel-
Biskis-Jinkins osteosarcoma oncogene (Fos), thymoma viral
oncogene homolog 2, and others in response to the treatment
of mice with diffusers. Tkatchenko et al. [29] observed that
the mRNA expression of several genes associated with cell
division were changed in primate retina following lid-fusion.
As yet, no distinct pathways for the retinal control of eye
growth  have  been  defined.  Therefore  there  are  still  no
validated  targets  for  pharmacological  intervention.  The
present study was aimed at finding new candidate genes that
could be involved in the generation of a stop signal for axial
eye growth. Unlike other studies, which addressed the signals
for myopia development induced by negative lens or diffuser
wear, this study was designed to identify genes involved in
hyperopia development. To this end, both eyes of each chick
were  covered  with  positive  lenses.  Since  hyperopia
development  requires  an  inhibitory  signal  for  axial  eye
growth,  identification  of  such  a  signal  could  provide  an
effective way to inhibit myopia. Retinal mRNA expression
patterns were compared between positive lens-treated and
untreated  chicks.  The  visually  induced  changes  in  the
transcription  of  potential  candidate  genes  were  further
investigated by semiquantitative real-time RT–PCR.
METHODS
Treatment of the animals: All experiments were conducted in
accordance with the ARVO statement for the use of Animals
in  Ophthalmic  and  Vision  Research  and  approved  by  the
University Commission for Animal Welfare (reference AK
6/05). One day old male white leghorn chickens obtained from
a local hatchery in Kirchberg, Germany, were raised under a
12 h:12 h light-dark cycle (light-onset: 8:00 AM and light-
offset: 8:00 PM) with unrestricted access to water and food
pellets  (chicken  breeding  pellets,  RKW-Sued,  Würzburg,
Germany).  No  additional  vitamins  or  supplements  were
added. On the day before the experiment started, the chicks
were placed under diethylether anesthesia and a velcro ring
was glued to the feathers around each eye. At the age of 9 days,
18 chicks were split into three experimental groups of six. One
group wore +6.9D lenses binocularly for 24 h. The second
group wore +6.9D lenses for 4 h, while the third group wore
−7D lenses for 24 h. For each group, six untreated control
chicks of the same batches were included in the analyses to
ensure that the treated samples and the control samples were
similarly processed. Because of the short treatment period, no
additional measurements of the chicks were performed (e.g.,
A-scan or measurement of refractive state). Also, we did not
control for the viewing distances because it was already shown
that chicks receive consistent myopic defocus on the retina
under our experimental conditions [30]. Chicks were killed by
an  overdose  of  diethylether.  Afterwards,  both  eyes  were
enucleated and the retinas were separated. The retina of both
eyes were pooled and RNA was extracted using the RNeasy
Mini  Kit  (Qiagen,  Hilden,  Germany),  according  to  the
manufacturer’s  instruction.  Microarray  experiments  were
performed with four of the six samples of the group treated
with +6.9D lenses for 24 h. All six samples of each group were
analyzed using real-time RT–PCR.
Microarrays:  Microarray  analysis  was  performed  by  the
Affymetrix Resource Facility at the University of Tuebingen.
RNA was quantified and checked for quality with the Agilent
2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA). The
RNA integrity numbers (RIN) ranged from 9.2 to 9.5 (with 1
being the most degraded profile and 10 being the most intact)
[31]. The GeneChip Chicken Genome Array (Affymetrix,
Santa  Clara,  CA)  was  used  with  a  coverage  of  32,773
transcripts, corresponding to over 28,000 chicken genes.
Next 1.5 µg total RNA (1.5 µg) was reverse transcribed
using  a  T7-oligo  (dT)  promotor  primer  in  the  first-strand
cDNA  synthesis.  After  RNaseH-mediated  second-strand
synthesis, the double-stranded cDNA was purified and served
as a template in the subsequent in vitro transcription reaction.
This was performed in the presence of T7 RNA polymerase
and a biotinylated nucleotide analog/ribonucleotide mix for
complementary  RNA  (cRNA)  amplification  and  biotin
labeling.  The  biotinylated  cRNA  targets  were  cleaned  up
according to the standard affymetrix protocol, fragmented,
and hybridized to GeneChip expression arrays, followed by
an automated washing and staining protocol (with streptavidin
phycoerythrin conjugate) on the fluidics station. Scanning and
analysis were performed using the Affymetrix Microarray
Suite Software (version 5.0).
The signal intensities were analyzed using ArrayAssist
4.0 (Stratagene, La Jolla, CA). Results were corrected for
multiple testing using the Benjamini/Hochberg paradigm with
a  false  discovery  rate  (FDR)  of  6%.  Each  data  set  was
normalized using three different normalization methods (GC-
RMA,  RMA,  MAS5),  with  GC-RMA  being  our  method
choice for further analyses. The mRNA expression levels of
genes of treated and untreated chicks were compared using
unpaired t-tests.
Real-time RT–PCR: Sixteen genes that were found in the
microarray  analysis  were  selected  for  further  analysis.
Selection  criteria  were  high  fold-changes  or  p-values,
interesting biologic functions (e.g., transporter- or molecular
transducer activity), differential expression of several probe-
sets of one gene present on the chip and already described
changes  of  mRNA  expression  of  these  genes  in  other
microarray-studies. Semiquantitative real-time RT–PCR was
used to assess mRNA expression levels of the selected genes.
Next, 1 µg RNA from each sample was reverse transcribed
with  M-MLV  reverse  transcriptase  (Promega,  Mannheim,
Germany) using 0.5 µg oligo(dT)15 primer and 50 ng of a
random  primer  mixture  (Invitrogen,  Solingen,  Germany).
QuantiTect SYBR Green master mix kit (Qiagen) was used
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Time PCR Detection System from Bio-Rad (Hercules, CA).
Samples were analyzed in triplicate with a template amount
corresponding  to  2  ng  of  RNA.  Hypoxanthine-
phosphoribosyl-transferase  (HPRT)  was  used  as  a
housekeeping gene. Primer sequences and NCBI accession
numbers are shown in Table 1, as well as the averaged relative
expression  levels  of  the  control  animals  determined  by
microarray analysis. The amplification efficiency (E) for all
gene-specific primer pairs were evaluated using a dilution
series as previously described [32]. Briefly explained, it was
calculated from cDNA standard curves by means of the slope
of the regression line with the equation: Efficiency = [10(-1/
slope)] - 1, whereby a value of 1.0 corresponds to 100%
efficiency and a value lower than 1.0 indicates an inhibition
of the reaction or poor primer binding.
Pathway analysis: GC-RMA normalized microarray data was
analyzed  using  the  software  Ingenuity  Pathways  Analysis
(Ingenuity  Systems).  As  the  program  did  not  contain
annotations for the chicken genome, the human homologs of
the 123 differentially expressed genes were used instead.
Statistics and data analysis: Data were analyzed using Excel
and the software package JMP 5.1 (SAS Institute GmbH,
Munich, Germany). The mean cycle threshold (Ct) value of
each triplet was taken and transformed into Mean Normalized
Expression (MNE), with HPRT as a housekeeping gene as
previously described [16]. Data were transformed with the
common logarithm to obtain a more normal distribution. Since
real-time  RT–PCR  of  each  treatment  group  (+6.9D/24  h,
+6.9D/4  h,  −7D/24  h)  was  performed  together  with  an
individual  control  group,  we  used  an  unpaired  t-test  to
compute  the  mean  differences  (deltaMNE)  and  the  95%
confidence interval in the MNE-values between every treated
group and its individual control group. Given that there was
no change in any of the genes tested after 4 h of +6.9D lens
treatment, these data were not included in the subsequent
analysis.
RESULTS
Microarray analysis: Using a p-value that was below 0.05, a
fold change (FC) of at least 1.5-fold and a false-discovery rate
of 6%, we found 123 genes to be differentially expressed after
24 h of treatment with +6.9D lenses (Appendix 1, GC-RMA
normalized  microarray  data).  Interestingly,  two  already
known candidate genes, glucagon and ZENK (EGR1), were
part of this list. The comparison of mRNA levels in retina of
eyes  treated  with  positive  lenses  to  those  without  lenses
revealed maximum fold changes of +11.8 (upregulation) of
the ras homolog gene family, member G (RHOG) mRNA and
−7.7 (downregulation) of CD226 mRNA (Appendix 1). We
found  67  of  all  differentially  expressed  genes  were
upregulated in the positive lens-treated eyes, and 56 were
downregulated (unpaired t-tests). According to gene ontology
annotations, most of those with known function had catalytic
activity or were involved in binding (Appendix 1).
The cytobands for the known human counterparts are
given in Appendix 1 as well. The human homologs of six
genes were found to be localized in chromosomal regions that
TABLE 1. DESCRIPTION OF PRIMERS
Gene
NCBI accession
number
Forward primer (5′-3′) Reverse primer (5′-3′) Amplicon
Averaged relative
signal intensity of
controls
HPRT NM_204848 TGGCGATGATGAACAAGGT GCTACAATGTGGTGTCCTCCC 162 bp 735
ABCC10 XM_419506 CTATGCTCTCGGGCTCTTTG GACAGTGAAGCAGGAAAGGC 166 bp 53
ACVR1 NM_204560 CGGAGGTCTTGGACGAAAC GGATCATTTGGAACCAGGTC 166 bp 19
ATE1 NM_001079733 TACTGGCTGGATGGGAAGATAA GCTTTCTCGTGAAGTTGC 164 bp 93
CD226 XM_001235284 TAGACAATGTGGAAGGAAGGT TGTATGCCATAGATAGGATGC 169 bp 111
CHRNB2 NM_204813 TGCTGGTGACCTTCTCCATCGT AGTTCTGCTGCGGCTGCTT 150 bp 35
ELF1 NM_001006269 CACAGGAACAAAGGGAGGAT GGATGTACTGGCTGCGTAGA 153 bp 13
ETV5 XM_422651 TCTGGCAGTTCCTCGTCA GCCCTTCTCGTAGTAGTAGCG 191 bp 287
GHRHR NM_001037834 CTTGGCATTCGGCTTTATTT GGCACAGTCCATCTTGTCCT 170 bp 7
GNAT2 NM_204690 GCTCCACATCACTGTTCTGCTG TGCCCGTTTCCTCTTCCCCT 224 bp 10078
GRB2 NM_204411 ATCTCCTCTGGGTGGTGAAG GATAAAGTCTCCACGGCGG 212 bp 73
MKP2 NM_204838 AGCCCTGCTGAACGTCTCA AGGGATGCACTTGTACTGGTAGTG 70 bp 29
OSBP2 XM_415293 GTGGTGAGTGATGCTGATGG CTTTGGGGACAGTGTCTGGT 149 bp 14
REEP6 XM_424848 TGGTGTATGGCGTCTTCAGT CACGGTGGTGTTTGAGGAA 180 bp 167
SHQ1 XM_414429 CGAAGAAATCAAGGACAGCA CAAATCCATAGTAGCACTGAAG 159 bp 28
SPTBN1 XM_419291 GCCATTGAAACAGACATTG CCCACAGGCGTATAACATTG 136 bp 20
pp-URP NM_206989 TGTGAAGCCTCAGCACCCTCT CCATCCTCCCCCAAACCTACT 148 bp 159
Shown are all genes that were investigated by real-time RT–PCR, together with NCBI accession number, primer sequence and
product  length. The averaged relative expression level of the control animals was determined by microarray analysis and reflects
the relative abundance of the transcript.
Molecular Vision 2008; 14:1589-1599 <http://www.molvis.org/molvis/v14/a189> © 2008 Molecular Vision
1591are already known to be associated with myopia. These genes
are shown in italic font and are underlined. Tetratricopeptide
repeat containing 3 (TMTC3) is located on the MYP3 locus,
similar to EMO2 (LOC416957) on MYP6, glutamine and
serine rich 1 (QSER1) on MYP7, neuroligin 1 (NLGN1) on
MYP8, doublecortex (DCX) on MYP13, and grainyhead-like
3 (GRHL3) on MYP14. Until now, none of these genes were
considered as a candidate gene for human myopia.
Different genes were identified if other normalization
methods were used. The MAS5 normalization method yielded
a  high  number  of  differentially  expressed  genes  (1030)
whereas RMA normalization yielded only 31 differentially
regulated genes (cut-off level was again a minimum FC of 1.5
and a p-value below 0.05 in both cases). In a comparison of
all normalization methods, we observed that only 21 genes
appeared in all three lists.
Data obtained by GC-RMA normalization (123 genes)
were  also  analyzed  using  Ingenuity  Pathways  Analysis
software, but no distinct pathways were identified based on
the changes in mRNA expression.
Real-time RT–PCR: Sixteen genes were chosen for validation
using real-time RT-RCR. Seven of these 16 genes were taken
from the list of 21 that were found with all three normalization
methods  (CD226,  GHRHR,  GNAT2,  OSBP2,  SHQ1,
SPTBN1, pp-URP), and nine additional genes were chosen
from  the  list  of  differentially  expressed  genes  that  were
obtained after GC-RMA normalization (genes shown in bold
in Appendix 1). Table 2 compares the results of the real-time
RT–PCR with the microarray analysis. The tissue originated
from the chicks treated with +6.9D lenses for 24 h. All four
microarray samples were tested by real-time PCR as well. In
addition, two samples that were not subjected to microarray
analysis were tested with real-time PCR.
Nine out of the 16 tested genes could be confirmed by
real-time PCR and are shown in bold font in Table 2. We
compared the fold-changes in gene expression levels between
GC-RMA microarray scores and real-time PCR of all tested
genes  and  found  a  significant  orthogonal  correlation
(correlation coefficient=0.759; n=16).
Two  additional  experimental  paradigms  were  used  to
further elucidate the possible roles of the nine validated genes
(+6.9D lenses for 4 h, −7D lenses for 24 h). None of the nine
genes showed significantly altered mRNA expression levels
after 4 h of treatment with +6.9D lenses (n=6; results not
shown). Changes in expression following either −7D or +6.9D
lens treatment (n=6 for each group) for 24 h are shown in
Figure  1.  The  mean  differences  of  the  normalized  gene
expressions (deltaMNE) between each treated group and its
individual  control  group,  as  well  as  the  95%  confidence
intervals are plotted.
The horizontal gray line in Figure 1 represents the level
of no difference in expression. No overlap between the 95%
confidence interval bars and this line indicates that there was
a statistically significant difference between the treated group,
and  the  respective  untreated  control  group.  Significant
differences between negative and positive lens-treated groups
are denoted by asterisks in Figure 1 (p<0.05 each).
Based on the real-time RT–PCR experiment, the genes
could  be  clustered  into  two  categories.  The  first  cluster
includes genes that showed changes in the same directions, no
matter whether positive or negative lenses were used: “image
sharpness detection” (ATE1, ELF1, GRB2, SHQ1, SPTBN1,
and  pp-URP).  In  this  cluster,  positive  lenses  as  well  as
negative  lenses  induced  significant  changes.  The  second
group  includes  those  genes  that  were  regulated  only  in
response to positive lens wear, but remained unchanged in
response to treatment with negative lenses: “sign of defocus
detection” (ABCC10, CD226, OSBP2).
GRB2,  SPTBN1,  ABCC10,  and  OPBP2  were
differentially  expressed  in  response  to  +6.9D  and  −7D
treatment. Both GRB2 and SPTBN1 showed an upregulation
after positive and negative lens treatment but the upregulation
was more pronounced in the negative lens-treated animals.
This suggests a graduated regulation of the transcription of
these genes with the absolute amount of defocus. ABCC10
expression was significantly downregulated in the positive
lens-treated animals, but upregulated in the negative lens-
treated animals. OSBP2 displayed no changes in response to
Figure  1.  Results  of  the  real-time  PCR  experiment.  The  mean
differences in gene expression (shown as delta Mean Normalized
Expression values, deltaMNE) and their 95% confidence intervals
between the lens-treated groups (24 h treatment with +6.9D and −7D
lenses, respectively) and the untreated control groups (n=6 animals
each) are shown for the nine genes for which the microarray data
could  be  confirmed.  The  horizontal  gray  line  at  fold  change  1
indicates  no  change.  Asterisks  denote  significant  differences
(p<0.05) between the two groups. Unpaired t-tests were performed,
and  not  corrected  for  multiple  testing.  Genes  were  assigned  to
clusters  depending  on  the  directions  of  the  changes  (Cluster  1:
changes in the same direction under both conditions; Cluster 2: only
regulated in response to positive lens treatment).
Molecular Vision 2008; 14:1589-1599 <http://www.molvis.org/molvis/v14/a189> © 2008 Molecular Vision
1592the treatment with negative lenses, but there was a significant
upregulation in the positive lens-treated animals.
The  data  discussed  in  this  publication  have  been
deposited  in  the  National  Center  for  Biotechnology
Information (NCBI's) Gene Expression Omnibus (GEO) and
are  accessible  through  GEO  Series  accession  number
GSE11439.
DISCUSSION
While changes in retinal gene expression associated with the
development  of  myopia  have  been  described  in  previous
reports, this is the first study to examine gene expression
changes during development of experimental hyperopia. This
approach was chosen because we were interested in potential
candidates for “stop signals” of axial eye growth. Using GC-
RMA for normalization of the microarray data, we found 123
differentially regulated genes after one day of positive lens
wear. The finding that two already known candidate genes,
glucagon and ZENK (EGR1), were in this list underlines the
usefulness of the microarray technique in discovering genes
that  underlie  the  targeted  biologic  processes.  Expression
changes were confirmed by real-time PCR for nine of 16
genes. Changes in mRNA expression patterns of the validated
genes were further studied in additional treatment groups. A
short treatment period of 4 h did not influence the mRNA
expression level of these genes, whereas some of them showed
significant changes after one day of negative lens treatment.
Different  normalization  methods—It  was  not
especially surprising to see that the different normalization
methods (GC-RMA, RMA, and MAS5) produced variable
results regarding the total number of differentially expressed
genes, with little overlap between the studies (only 21 genes).
This was similar to a previous microarray study undertaken
by Brand et al. [28]. There are major differences between GC-
RMA,  RMA,  and  MAS5  normalization  methods:  MAS5
corrects for hybridization to the mismatch probes for that
particular  probe  set,  whereas  GC-RMA  and  RMA
alternatively  calculate  a  background  adjustment  step  that
ignores the mismatch intensities [33]. Millenaar et al. [34]
evaluated multiple normalization methods and found MAS5
to have the most distinct outcome compared to the other two
procedures. However, the differences were much smaller in
their study compared to ours. We chose seven genes that were
represented in all lists (GC-RMA, RMA, and MAS5) for
validation by semiquantitative real-time RT–PCR. As a result,
five  genes  could  be  verified—which  represents  a  higher
percentage than with the GC-RMA normalized data list. We
therefore agree with the conclusion by Brand and colleagues
[28] that each normalization method likely provides only a
fragmentary picture of all changes in gene expression.
Magnitude of changes in gene expression—We found
only small changes in gene expression in positive lens-treated
chicks, involving 123 genes with an average fold change of
TABLE 2. RESULTS OBTAINED BY MICROARRAY ANALYSIS AND REAL-TIME RT-PCR
Gene Fold change PCR p-value PCR Fold change MA p-value MA
ABCC10 -1.23 0.0385 -1.59 0.0047
ACVR1 1.17 0.1975 -1.63 0.0180
ATE1 1.32 0.0149 1.56 0.0093
CD226 -2.54 0.0318 -7.70 0.0247
CHRNB2 1.31 0.0082 -1.50 0.0314
ELF1 1.24 0.0446 1.83 0.0069
ETV5 1.10 0.2014 -1.51 0.0000
GHRHR 2.07 0.1160 3.08 0.0056
GNAT2 1.09 0.4197 -2.49 0.0005
GRB2 1.27 0.0245 1.50 0.0150
MKP2 -1.36 0.1374 -1.75 0.0162
OSBP2 1.27 0.0059 4.00 0.0412
pp-URP -1.81 0.0045 -2.50 0.0010
REEP6 1.23 0.0912 -2.03 0.0331
SHQ1 3.62 0.0077 4.03 0.0214
SPTBN1 1.39 0.0071 2.90 0.0011
Shown are data from retinal samples of chicks that were treated with +6.9D lenses for 24 h. The numbers represent fold-changes
and p-values for the changes of the investigated genes in both the real-time RT-PCR (PCR) and the microarray (MA) experiment.
Genes shown in bold were further tested with real-time RT–PCR in two other experimental paradigms: treatment with +6.9D
lenses for 4 h or with −7D lenses for 24 h.
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Microarray data: ±1.96. The magnitudes of changes are in line with the findings
of other microarray studies [27,28]. It is known that even small
changes in the expression of biologically relevant transmitters
or neuromodulators can cause large effects. For instance, the
drop  in  retinal  dopamine  levels  associated  with  the
development  of  form-deprivation  myopia  in  chicks  (e.g.,
Stone et al. [14]) did not exceed 30%. In addition to the
regulation at the transcriptional level, the processing/transport
and the translation and stability of mRNA regulate the protein
(expression)  level.  For  instance,  a  study  in  yeast,  where
changes in mRNA levels and protein levels were compared,
showed  that  at  least  20%  of  the  changes  in  mRNA
concentrations did not show up as parallel changes in protein
levels  [35].  And  finally,  as  the  total  retinal  tissue  was
processed,  potentially  large  local  cell-specific  changes  in
mRNA concentrations could have been averaged out.
Treatment time and biochemical changes—It has been
found  in  previous  studies  [36,37]  that  changes  in  retinal
mRNA levels occur as early as after 24 h of treatment with
spectacle lenses. Negative lens treatment was observed to
cause a significant decline in glucagon mRNA levels [16] and
positive lens treatment an increase in glucagon mRNA levels
[38].  The  same  treatment  duration  induced  changes  in
proteoglycan synthesis in the chick sclera [39] and changes in
expression  of  collagen-binding  integrin  receptors  in  tree
shrew sclera [40], suggesting that active remodeling of the
distinct layers of the eye was already in progress.
Some changes in gene expression can also occur much
earlier. For example, the concentration of the mRNA of the
transcription factor ZENK is changed already after 15–30 min
[18-20].  Some  of  the  early  events—for  example,  ZENK
expression  changes—may  persist  after  one  day  of  lens
treatment (ZENK mRNA level remains low after one day of
negative  lens  treatment)  or  even  reverse  the  direction  of
changes  (ZENK  mRNA  levels  are  upregulated  by  short
periods  of  positive  lens  wear  [19]  but  seem  to  be
downregulated by longer periods of positive lens treatment
[41]).
That the nine validated genes did not show any significant
changes, or even a trend toward a change, after only 4 h of
positive lens treatment suggests that they are not essential in
the early signaling cascade in the retina following imposed
defocus.
Validation and characterization of genes with real-time
RT–PCR:  It  was  possible  to  confirm  nine  out  of  16
differentially  expressed  genes.  Nevertheless,  some  of  the
microarray results were not confirmed. One explanation for
the failure of the validation of some of the microarray results
may  be  alternative  transcript  usage  as  a  technical  and
conceptual issue in comparing across species and studies. A
recent  study  characterized  alternate  splicing  and  tissue-
specific expression in the chicken from expressed sequence
tags [42]. The authors suggested that alternate splicing may
occur in 50%–60% of the chicken gene set with an average of
more  than  two  transcripts  per  gene  which  undergo  this
process. This underlines that real-time PCR validation may
fail  in  some  cases,  because  most  genes  have  several
transcripts: the sequences that were amplified with the primer
pairs of three of the genes that could not be validated in our
study (REEP6, MKP2, and GHRHR) did not include the same
region of the gene against which the microarray probes had
been  designed.  The  other  four  genes  that  could  not  be
validated were presented more than once on the microarray,
with only one probe set showing differential expression. The
possibility of the presence of yet to be known isoforms can
therefore  not  be  excluded.  Moreover,  microarrays  and
semiquantitative  PCR  require  and  utilize  vastly  different
normalization methods.
Comparisons with other microarray studies: In similar
microarray studies [27-29], only a small number of genes were
changed by visual conditions that induce refractive errors.
Unfortunately, there is little overlap among the lists from
different  studies.  Different  normalization  methods  may
account for part of the problem, but differences in treatment
paradigms, animals, and samples (pure retina versus retina/
RPE) are also the case. Comparisons of different studies are
shown in Table 3, together with the individual normalization
methods.
McGlinn et al. [27] studied form vision-deprived chicks
after 6 h and 3 days and analyzed the retina/RPE tissue with
the GeneChip Chicken Genome Arrays (Affymetrix). Three
genes were significantly changed in both their study and ours:
pp-URP,LOC424393  (the  homolog  to  the  human  BAT2
domain containing 1), and the clone ChEST955o8. Not much
is known about the function of pp-URP (see McGlinn et al.
[27] for more details). As stated by these authors, pp-URP
merits  future  investigation  since  it  is  implicated  in  the
activation of the urotensin receptor, which then is able to
stimulate  growth  signaling  pathways  [43].  Since
LOC424393 and pp-URP were changed in the same direction
during form deprivation myopia and lens-induced hyperopia
development, there is no link to the sign of axial eye growth
changes. Unfortunately, no information is available about the
only  gene  that  was  differentially  regulated  during  form-
deprivation  myopia  and  lens-induced  myopia
(ChEST955o8).
Brand et al. [28] deprived mice of form vision in one eye
for different durations (30 min, 4 h, 24 h). They then compared
the mRNA expression in the form-deprived retina to the one
in the fellow eye, which had been treated with neutral density
filters  to  match  light  attenuation.  Three  genes  were
consistently changed in both their study and ours. Caldesmon
1 mRNA, an ubiquitous actin- and calmodulin-binding protein
[44], which is also a substrate for mitogen-activated protein
kinase [45] and other serine and threonine kinases [46-48] was
downregulated  in  both  studies,  GTPase  activating  Rap/
RanGAP  domain-like  1  mRNA  was  upregulated  in  both
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downregulated in both studies.
Finally, Tkatchenko et al. [29] performed a microarray
study of retinas from rhesus macaques and green monkeys
who had been deprived of form vision by surgical lid-fusion.
A  comparison  between  both  lists  is  difficult  because  the
authors  had  constructed  their  own  microarrays  and  had
normalized  the  data  against  the  expression  of
glyceraldehyde-3-phosphate  dehydrogenase  mRNA.
Therefore, the GC-RMA normalized data were compared with
the list of Tkatchenko and colleagues. Only one gene showed
up in both lists: Rho guanine nucleotide exchange factor 12
mRNA, which was upregulated in both cases.
Since  all  these  genes,  except  for  ChEST955o8,  were
regulated  in  the  same  direction  both  during  myopia  and
hyperopia development, they are most likely not linked to
pathways specific for either stimulation or inhibition of eye
growth.
Localization  of  genes  to  known  myopia  loci:  Human
homologs, if known, were tested for possible localization at
already known chromosomal susceptibility loci. Six genes
mapped to regions that were already known to be associated
with  myopia  in  different  families.  Five  of  them  were
upregulated  during  induction  of  hyperopia  with  positive
lenses (DCX, NLGN1, QSER1, TMTC3, and LOC41695) and
one was downregulated (GRHL3). DCX is a cytoplasmatic
protein suspected to direct neuronal migration by regulating
the  organization  and  stability  of  microtubules  in  the
developing cortex [49]. NLGN1 is a neuronal cell-surface
protein that may be involved in the formation and remodeling
of  central  nervous  system  synapses  [50].  No  further
information is available at present about the possible function
of QSER1, TMTC3, and C22orf30 (the human homolog of
LOC416957). GRHL3 probably acts as a transcription factor
during development [51]. Although none has been detected in
human myopia linkage studies, these genes may represent new
candidates for future linkage analyses.
New  candidate  genes:  The  genes  that  were  closer
investigated  by  real-time  RT–PCR  are  described  in  more
detail in the next section. None of these genes has a known
function in the retina.
ABCC10—ABCC10 is supposed to be a lipophilic anion
transporter,  most  likely  involved  in  phase  III  (cellular
extrusion) of detoxification [52]. So far, no involvement in
retinal processing has been proposed. Therefore, speculations
about the function of ABCC10 in the signaling cascade in the
retina  are  difficult.  Nevertheless,  ABCC10  merits  further
TABLE 3. A COMPARISON OF GENE LISTS WITH OTHER STUDIES
Affymetrix ID
 Gene
symbol
FC
Schippert
  FC
others
p value
Schippert Gene title Normalization
Gga.19434.1.S1_at
 
-1.64 1.26 0.0252 Finished cDNA,              both RMA
clone ChEST955o8
Gga.8944.3.S1_s_at LOC424393 1.78 1.23 0.0004 similar to                         both RMA
KIAA1096 protein
Gga.9482.1.S1_at LOC404534 -1.83 -1.67 0.0004 prepro-urotensin II-         both RMA
related peptide
Comparison with Brand et al. [28]
GgaAff × 0.21017.1.S1_s_at CALD1 -1.65 -2.65 0.0295 caldesmon 1 both MAS5
Gga.10521.1.S1_s_at GARNL1 1.57 1.51 0.0016 GTPase activating           both MAS5
Rap/RanGAP
domain-like 1
Gga.9350.1.S1_s_at KNTC2 -4.41 -3.52 0.0491 kinetochore                     both MAS5
associated 2
Comparison with Tkatchenko et al. [29]
GgaAff × 0.4150.3.S1_s_at ARHGEF12 1.55 Upregulation
(FC
unknown)
0.0213 similar to Rho
guanine nucleotide
exchange factor 12
GCRMA/GAPDH
Comparisons of the list of differentially expressed genes found in the present study with microarray studies from other groups
[27-29].  Shown are Affymetrix ID, gene symbol, fold changes of the respective gene in the present study (FC Schippert) and
in the respective other studies (FC others), p-values obtained in this study (p-value Schippert), gene title, and normalization
methods used.
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Comparison with McGlinn et al. [27]investigation because it was downregulated in positive lens-
treated chicks and, compared to this group, upregulated in
negative lens-treated animals.
ATE1—This protein is an enzyme that is involved in the
targeting  of  proteins  for  ubiquitin-dependent  degradation
[53]. It has been shown that in ATE1−/− embryos, the Gq/Gi-
activated extracellular signal-regulated kinase pathways were
impaired. In these embryos, the mRNA expression of v-jun
sarcoma  virus  17  oncogene  homolog,  FOS,  3-
phosphoinositide dependent protein kinase-1 and Cyclin D1
was  found  to  be  downregulated  by  roughly  twofold  [54].
Despite the upregulation of ATE1 in both the positive- and the
negative lens-treated group, none of the aforementioned genes
was found to be differentially expressed in our study.
CD226—This glycoprotein is expressed on the surface
of natural killer cells, platelets, monocytes, and a subset of T
cells. It is a member of the immunoglobulin superfamily and
mediates  cellular  adhesion  to  other  cells  bearing  an
unidentified  ligand.  Cross-linking  CD226  with  antibodies
initiates  platelet  activation  and  aggregation  in  a  process
dependent on the Fc receptor and protein kinase C activation
[55,56]. That CD226 was most strongly downregulated in the
24 h positive lens-treated animals lends credence to the belief
that these changes are somehow related to changes in axial
growth—even if the mode of action remains unknown.
ELF1—This  transcription  factor  regulates,  among
others, inducible gene expression during T cell activation
[57]. ELF1 and repellent axon guidance signal have been
implicated in the control and development of the retinotectal
projection  [58].  ELF1  was  upregulated  after  positive  and
negative lens treatment, suggesting that it is part of a more
general response of the retina, rather than a specific signal for
directional growth changes.
GRB2—GRB2 is an adaptor protein involved in signal
transduction  [59]  by  mediating  the  activation  of  RAS  in
complex with epidermal growth factor receptor and son of
sevenless (SOS) [60]. It is implicated in the insulin pathway,
and insulin itself has been shown to lead to excessive eye
growth  [61,62].  Insulin  receptor  substrate  protein  1  is
phosphorylated by the insulin receptor and is then able to bind
GRB2, which then activates the mitogen-activated protein
kinase  pathway  through  its  interaction  with  SOS.
Additionally, GRB2 has been linked to the internalization of
beta-adrenergic receptors in response to insulin [63].
There are 43 insulin-related, seven SOS-related, and 25
epidermal growth factor-related sequences on the Affymetrix
chip, none of which was differentially expressed in the retina
of positive lens-treated eyes. GRB2 interacts with 190 other
proteins (see Human Protein Reference Database) and may
well have other yet to be defined functions as suggested by
the upregulation in negative lens-treated eyes as compared to
the positive lens-treated eyes.
OSBP2—OSBP2  and  OSBP1  have  previously  been
shown to be located in the retina with OSBP1 being more
abundant. OSBP1 is not on the Affymetrix chip. OSBP1 and
OSBP2 are expressed in different types of retinal cells with
OSBP2  likely  to  be  associated  with  membranes  in  a  yet
unknown way [64]. Oxysterols are oxidized byproducts of
cholesterol that can cause cytotoxic effects, with low-density
lipoprotein (LDL) being one of the major sources of oxidized
cholesterol. OSBPs bind oxysterol, and are highly expressed
in the RPE, which also expresses the LDL-receptor [65]. This
suggests  that  the  RPE  has  a  mechanism  to  bind  these
oxysterols  as  they  are  released  from  the  LDL  complex.
Another  link  could  be  established  to  apolipoprotein  A1
(ApoA-I), whose level was elevated in the retina after the
development of hyperopia [66], and the LDL-receptor. ApoA-
I acts as a ligand for these receptors in chickens, comparable
to the LDL receptor-related protein, which has been shown to
regulate plasminogen and matrix metalloproteinase activation
[67].
SHQ1—SHQ1  is  an  essential  nuclear  protein  that  is
involved in rRNA processing pathways. Together with the
protein  NAF1  it  is  important  in  the  initial  steps  of  the
biogenesis of small nucleolar RNAs (snoRNAs). SnoRNAs
later form small nucleolar ribonucleoprotein particles, which
are  essential  cofactors  in  ribosomal  RNA  metabolism.
SHQ1 was upregulated in both treatment groups, with a much
higher variation between the six samples measured in the
positive lens-treated group.
SPTBN1—SPTBN1 is a cytoskeletal protein involved
with organizing receptor domains and possibly the control of
vesicle traffic at the plasma membrane [68]. It interacts with
calmodulin and calcium-dependent protease 1. SPTBN1 has
been proposed to play a role in local mechanisms that can
control rapid changes in membrane topography and skeletal
organization and yet provide permanence and stability to the
membrane between cycles of change [69]. Since SPTBN1
mRNA  expression  was  generally  upregulated  in  both  the
positive- and the negative lens-treated group, we propose a
more general role of this protein in retinal processing.
pp-URP—pp-URP II-related peptide is the precursor of
the  urotensin  II  paralog  (URP).  It  binds  to  the  G-protein
coupled  urotensin  II  receptor  (UTS2R),  which  was  also
downregulated in our experiment (Appendix 1, Molecular
Transducer  Activity,  FC=-1.51;  Affymetrix  ID:
GgaAff × 0.1067.1.S1_at). If the effect of URP is indeed the
same as of urotensin II, binding to the UTS2R leads to Gq
protein activation, associated with activation of protein kinase
C, protein tyrosine kinases, calmodulin, and phospholipase C
[70-72].  Urotensin  II  also  induces  c-fos,  which  has  been
shown to be reduced in the retina of form-deprived mice [28].
This seems to support the possibility that pp-URP is involved
in eye growth regulation. Nevertheless, the down-regulation
of  pp-URP  in  both  cases  (positive-  and  negative  lens
treatment) leads us to the assumption that this molecule is part
of a general signaling pathway in the retina rather than a start-
or a stop-signal for axial growth.
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unknown genes that were regulated in the retina of chicks by
exposure to myopic defocus. At present, no defined pathways
could be associated with the observed changes. Apparently,
the retina responds to treatment with positive lenses for 24 h
with changes in several major signaling pathways (protein
kinase  C,  G-protein-coupled  receptors,  mitogen-activated
protein kinase). Comparisons with other published microarray
studies remain inherently difficult because of differences in
treatment  protocols,  animal  models,  and  normalization
methods. More closely matched experimental variables would
help to improve the situation in the future, but it could also be
that just more studies, especially studies that follow mRNA
changes over time, would be sufficient to generate to a more
coherent picture.
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Appendix 1. List of genes that were obtained by unpaired t-test and GC-
RMA analysis
To access the data, click Appendix 1. This will initiate
the download of a pdf that contains the file.
Chicks were treated for 24 h with +6.9D lenses. Eyes of
untreated chicks of the same batches served as controls (4
individuals  for  each  group).  Affymetrix  ID,  Fold  Change
(FC),  gene  title  and  chromosomal  position  of  the  human
homologs are shown. Genes were sorted after GO annotations.
Genes that were localized in chromosomal loci of the human
genome which are known to be associated with myopia are
underlined and in italics. Genes that were chosen for real-time
PCR validation are shown in bold.
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